Schumann Michael, Nakagawa Tomoo, Mantey Samuel A, Tokita Kenji, Venzon David J, Hocart Simon J, Benya Richard V, Jensen Robert T
Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Building 10, Rm. 9C-103, 10 Center Drive, MSC 1804, Bethesda, MD 20892, USA.
J Pharmacol Exp Ther. 2003 Nov;307(2):597-607. doi: 10.1124/jpet.103.055087. Epub 2003 Sep 11.
Little is known about the function of the central portion of the second intracellular loop (i2 loop) of peptide receptors in activation of downstream pathways and receptor modulatory processes such as receptor internalization or chronic down-regulation (DR). Recent data suggest a role for i2 loop hydrophobic amino acids in these processes. We used site-directed mutagenesis to address these issues with the gastrin-releasing peptide receptor (GRP-R). Each i2 loop residue from 142 to 148 was mutated and the receptors were expressed in Balb 3T3 cells. Two mutants showed a minimal (<2-fold) decrease in affinity. Five mutants showed decreased efficacy for activating phospholipase C (PLC). Two double mutants (IM143.147AA and VM144.147AA) showed a minimal decrease in affinity but had a decreased ability to fully activate PLC. Only the IM double mutation had decreased maximal internalization, whereas the R145A single mutant showed an increase, suggesting a tonic inhibitory role for Arg-145 in internalization. Three single and both double mutants showed decreases in receptor DR. There was a weak correlation between the extent of GRP-R internalization and the maximal PLC activation, whereas changes in the maximal PLC activation were significantly (p = 0.008) coupled to receptor DR. This study shows that amino acids of the i2 loop of the GRP-R are important in activation of PLC, internalization and down-regulation, but not for affinity. Our results support the proposal that internalization and chronic down-regulation have differing dependence on PLC and are largely independent processes, because some mutants showed no changes in internalization, but significant alterations in down-regulation.
关于肽受体第二个细胞内环(i2环)中央部分在下游信号通路激活以及受体调节过程(如受体内化或慢性下调(DR))中的功能,目前所知甚少。最近的数据表明i2环疏水氨基酸在这些过程中发挥作用。我们利用定点诱变技术,通过胃泌素释放肽受体(GRP-R)来解决这些问题。对142至148位的每个i2环残基进行了突变,并在Balb 3T3细胞中表达这些受体。两个突变体的亲和力仅有最小程度(<2倍)的降低。五个突变体激活磷脂酶C(PLC)的效能降低。两个双突变体(IM143.147AA和VM144.147AA)的亲和力仅有最小程度的降低,但完全激活PLC的能力下降。只有IM双突变体的最大内化作用降低,而R145A单突变体则表现出增加,这表明精氨酸-145在内在化过程中具有张力性抑制作用。三个单突变体和两个双突变体均表现出受体DR降低。GRP-R内化程度与最大PLC激活之间存在微弱的相关性,而最大PLC激活的变化与受体DR显著相关(p = 0.008)。这项研究表明,GRP-R的i2环氨基酸在PLC激活、内化和下调中起重要作用,但对亲和力无影响。我们的结果支持以下观点,即内化和慢性下调对PLC的依赖性不同,且在很大程度上是独立的过程,因为一些突变体的内化没有变化,但下调却有显著改变。